EU Moves To Ease Regulatory Burden On Pharma
Authorities Allow Flexibility During COVID-19 Pandemic
Executive Summary
Regulatory authorities have adapted the EU medicines framework to help pharmaceutical companies cope with the consequences of the COVID-19 pandemic.